BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 36661691)

  • 1. A Deep Learning Workflow for Mass-Forming Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma Classification Based on MRI.
    Liu Y; Wang B; Mo X; Tang K; He J; Hao J
    Curr Oncol; 2022 Dec; 30(1):529-544. PubMed ID: 36661691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implications of ultrasound-based deep learning model for preoperatively differentiating combined hepatocellular-cholangiocarcinoma from hepatocellular carcinoma and intrahepatic cholangiocarcinoma.
    Chen J; Zhang W; Bao J; Wang K; Zhao Q; Zhu Y; Chen Y
    Abdom Radiol (NY); 2024 Jan; 49(1):93-102. PubMed ID: 37999743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinguishing intrahepatic mass-forming biliary carcinomas from hepatocellular carcinoma by computed tomography and magnetic resonance imaging using the Bayesian method: a bi-center study.
    Ichikawa S; Isoda H; Shimizu T; Tamada D; Taura K; Togashi K; Onishi H; Motosugi U
    Eur Radiol; 2020 Nov; 30(11):5992-6002. PubMed ID: 32500195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deep learning for liver tumor diagnosis part I: development of a convolutional neural network classifier for multi-phasic MRI.
    Hamm CA; Wang CJ; Savic LJ; Ferrante M; Schobert I; Schlachter T; Lin M; Duncan JS; Weinreb JC; Chapiro J; Letzen B
    Eur Radiol; 2019 Jul; 29(7):3338-3347. PubMed ID: 31016442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential diagnosis of hepatocellular carcinoma and intrahepatic cholangiocarcinoma based on spatial and channel attention mechanisms.
    Huang JL; Sun Y; Wu ZH; Zhu HJ; Xia GJ; Zhu XS; Wu JH; Zhang KH
    J Cancer Res Clin Oncol; 2023 Sep; 149(12):10161-10168. PubMed ID: 37268850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differentiation of Intrahepatic Cholangiocellular Carcinoma from Hepatocellular Carcinoma in the Cirrhotic Liver Using Contrast-enhanced MR Imaging.
    Wengert GJ; Baltzer PAT; Bickel H; Thurner P; Breitenseher J; Lazar M; Pones M; Peck-Radosavljevic M; Hucke F; Ba-Ssalamah A
    Acad Radiol; 2017 Dec; 24(12):1491-1500. PubMed ID: 28756085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MRI features of combined hepatocellular- cholangiocarcinoma versus mass forming intrahepatic cholangiocarcinoma.
    Sammon J; Fischer S; Menezes R; Hosseini-Nik H; Lewis S; Taouli B; Jhaveri K
    Cancer Imaging; 2018 Feb; 18(1):8. PubMed ID: 29486800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinguishing intrahepatic cholangiocarcinoma from hepatocellular carcinoma in patients with and without risks: the evaluation of the LR-M criteria of contrast-enhanced ultrasound liver imaging reporting and data system version 2017.
    Li F; Li Q; Liu Y; Han J; Zheng W; Huang Y; Zheng X; Cao L; Zhou JH
    Eur Radiol; 2020 Jan; 30(1):461-470. PubMed ID: 31297632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Multiparametric Fusion Deep Learning Model Based on DCE-MRI for Preoperative Prediction of Microvascular Invasion in Intrahepatic Cholangiocarcinoma.
    Gao W; Wang W; Song D; Wang K; Lian D; Yang C; Zhu K; Zheng J; Zeng M; Rao SX; Wang M
    J Magn Reson Imaging; 2022 Oct; 56(4):1029-1039. PubMed ID: 35191550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic performance of magnetic resonance imaging and contrast-enhanced ultrasound in differentiating intrahepatic cholangiocarcinoma from hepatocellular carcinoma: a meta-analysis.
    Wu Y; Xia C; Chen J; Qin Q; Ye Z; Song B
    Abdom Radiol (NY); 2024 Jan; 49(1):34-48. PubMed ID: 37823913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can contrast enhanced ultrasound differentiate intrahepatic cholangiocarcinoma from hepatocellular carcinoma?
    Huang JY; Li JW; Ling WW; Li T; Luo Y; Liu JB; Lu Q
    World J Gastroenterol; 2020 Jul; 26(27):3938-3951. PubMed ID: 32774068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Applications of Dynamic Contrast-Enhanced Ultrasound in Differential Diagnosis of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma in Non-cirrhotic Liver.
    Dong Y; Chen S; Möller K; Qiu YJ; Lu XY; Zhang Q; Dietrich CF; Wang WP
    Ultrasound Med Biol; 2023 Aug; 49(8):1780-1788. PubMed ID: 37156676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Added-value of ancillary imaging features for differentiating hepatocellular carcinoma from intrahepatic mass-forming cholangiocarcinoma on Gd-BOPTA-enhanced MRI in LI-RADS M.
    Zheng W; Huang H; She D; Xiong M; Chen X; Lin X; Cao D
    Abdom Radiol (NY); 2022 Mar; 47(3):957-968. PubMed ID: 34964069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differentiation of intrahepatic cholangiocarcinoma from hepatocellular carcinoma in high-risk patients: A predictive model using contrast-enhanced ultrasound.
    Chen LD; Ruan SM; Liang JY; Yang Z; Shen SL; Huang Y; Li W; Wang Z; Xie XY; Lu MD; Kuang M; Wang W
    World J Gastroenterol; 2018 Sep; 24(33):3786-3798. PubMed ID: 30197484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contrast-enhanced ultrasound Liver Imaging Reporting and Data System: Lights and shadows in hepatocellular carcinoma and cholangiocellular carcinoma diagnosis.
    Vidili G; Arru M; Solinas G; Calvisi DF; Meloni P; Sauchella A; Turilli D; Fabio C; Cossu A; Madeddu G; Babudieri S; Zocco MA; Iannetti G; Di Lembo E; Delitala AP; Manetti R
    World J Gastroenterol; 2022 Jul; 28(27):3488-3502. PubMed ID: 36158272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detailed analysis of temporal features on contrast enhanced ultrasound may help differentiate intrahepatic cholangiocarcinoma from hepatocellular carcinoma in cirrhosis.
    Li R; Yuan MX; Ma KS; Li XW; Tang CL; Zhang XH; Guo DY; Yan XC
    PLoS One; 2014; 9(5):e98612. PubMed ID: 24874413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deep learning for liver tumor diagnosis part II: convolutional neural network interpretation using radiologic imaging features.
    Wang CJ; Hamm CA; Savic LJ; Ferrante M; Schobert I; Schlachter T; Lin M; Weinreb JC; Duncan JS; Chapiro J; Letzen B
    Eur Radiol; 2019 Jul; 29(7):3348-3357. PubMed ID: 31093705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DLNLF-net: Denoised local and non-local deep features fusion network for malignancy characterization of hepatocellular carcinoma.
    Huang H; Xie Y; Wang G; Zhang L; Zhou W
    Comput Methods Programs Biomed; 2022 Dec; 227():107201. PubMed ID: 36335751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LI-RADS-CEUS - Proposal for a Contrast-Enhanced Ultrasound Algorithm for the Diagnosis of Hepatocellular Carcinoma in High-Risk Populations.
    Schellhaas B; Wildner D; Pfeifer L; Goertz RS; Hagel A; Neurath MF; Strobel D
    Ultraschall Med; 2016 Dec; 37(6):627-634. PubMed ID: 27486793
    [No Abstract]   [Full Text] [Related]  

  • 20. Classification of hepatocellular carcinoma and intrahepatic cholangiocarcinoma based on multi-phase CT scans.
    Ponnoprat D; Inkeaw P; Chaijaruwanich J; Traisathit P; Sripan P; Inmutto N; Na Chiangmai W; Pongnikorn D; Chitapanarux I
    Med Biol Eng Comput; 2020 Oct; 58(10):2497-2515. PubMed ID: 32794015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.